ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 84 filers reported holding ALLOVIR INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $160,890 | -81.9% | 222,439 | -81.1% | 0.00% | – |
| Q1 2024 | $889,465 | +21.0% | 1,178,256 | +9.0% | 0.00% | – |
| Q4 2023 | $734,935 | -68.7% | 1,081,104 | -1.0% | 0.00% | – |
| Q3 2023 | $2,347,796 | -26.1% | 1,091,998 | +16.9% | 0.00% | – |
| Q2 2023 | $3,175,484 | -9.0% | 933,966 | +5.5% | 0.00% | – |
| Q1 2023 | $3,489,288 | -61.3% | 885,606 | -49.7% | 0.00% | – |
| Q4 2022 | $9,027,898 | +30.4% | 1,759,824 | +100.5% | 0.00% | – |
| Q3 2022 | $6,923,000 | +146.5% | 877,501 | +21.8% | 0.00% | – |
| Q2 2022 | $2,809,000 | -27.6% | 720,201 | +25.2% | 0.00% | – |
| Q1 2022 | $3,882,000 | -75.5% | 575,179 | -53.0% | 0.00% | -100.0% |
| Q4 2021 | $15,827,000 | -48.1% | 1,223,095 | +0.6% | 0.00% | -50.0% |
| Q3 2021 | $30,469,000 | -9.8% | 1,215,836 | -29.0% | 0.00% | 0.0% |
| Q2 2021 | $33,786,000 | -7.7% | 1,711,571 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $36,605,000 | +26.2% | 1,564,335 | +107.3% | 0.00% | 0.0% |
| Q4 2020 | $29,011,000 | +321.9% | 754,702 | +201.8% | 0.00% | – |
| Q3 2020 | $6,876,000 | – | 250,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $15,683,000 | 0.66% |
| GMT CAPITAL CORP | 1,138,070 | $7,682,000 | 0.48% |
| RA Capital Management | 1,440,525 | $9,724,000 | 0.21% |
| Redmile Group, LLC | 823,371 | $5,558,000 | 0.17% |
| Samsara BioCapital, LLC | 82,336 | $556,000 | 0.14% |
| Woodline Partners LP | 1,087,093 | $7,338,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 93,166 | $629,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,532 | $7,719,000 | 0.04% |
| Virtus ETF Advisers LLC | 10,463 | $71,000 | 0.03% |
| PDT Partners, LLC | 30,198 | $204,000 | 0.02% |